WHC is still in active development. Read this to understand our approach.
depiction of CKHJPWQVLKHBIH-UHFFFAOYSA-N.svg
tripsit

sulbutiamine

Verificar en tripsit

isomerdesign

Sulbutiamine

Verificar en isomerdesign

wiki

Sulbutiamine

Verificar en wiki

Data

InChI: InChI=1S/C32H46N8O6S2/c1-19(2)31(43)45-11-9-27(21(5)39(17-41)15-25-13-35-23(7)37-29(25)33)47-48-28(10-12-46-32(44)20(3)4)22(6)40(18-42)16-26-14-36-24(8)38-30(26)34/h13-14,17-20H,9-12,15-16H2,1-8H3,(H2,33,35,37)(H2,34,36,38)

Sinónimos: DTXCID3026641,Sulbutiamine,AKOS015965079,bisibutiamine,Vitaberin,SCHEMBL25578,[5-[(4-amino-2-methyl-pyrimidine-5-carbonyl)-methyl-amino]-3-[1-[(4-amino-2-methyl-pyrimidine-5-carbonyl)-methyl-amino]ethylidene]-4-[2-(2-methylpropanoyloxy)ethyl]-6,6-bis(sulfanyl)hex-4-enyl] 2-methylpropanoate;Sulbutiamine,sulbut,arcalion,Sulbutiamine (INN),3286-46-2,Youvitan,Tox21_112460_1,youvitan,BCP9000417,[(Z)-4-[(4-Amino-2-methylpyrimidin-5-yl)methyl-formylamino]-3-[[(E)-2-[(4-amino-2-methylpyrimidin-5-yl)methyl-formylamino]-5-(2-methylpropanoyloxy)pent-2-en-3-yl]disulfanyl]pent-3-enyl] 2-methylpropanoate,MFCD01726427,A821472,isobutyryl thiamine disulfide,ZINC150338505,HMS3886G15,Youvitan (TN),HY-B2229,D01319,AMY30241,Disulfanediylbis(4-(N-((4-amino-2-methylpyrimidin-5-yl)methyl)formamido)pent-3-ene-3,1-diyl) bis(2-methylpropanoate),Q-201756,enerion,s5203,NCGC00167456-02,CCG-270389,[(Z)-4-[(4-amino-2-methyl-pyrimidin-5-yl)methyl-formyl-amino]-3-[[(Z)-2-[(4-amino-2-methyl-pyrimidin-5-yl)methyl-formyl-amino]-1-[2-(2-methylpropanoyloxy)ethyl]prop-1-enyl]disulfanyl]pent-3-enyl] 2-methylpropanoate,Tox21_112460,CAS-3286-46-2,BCP05328,DTXSID5046641,[(Z)-4-[(4-amino-2-methylpyrimidin-5-yl)methyl-formylamino]-3-[[(Z)-2-[(4-amino-2-methylpyrimidin-5-yl)methyl-formylamino]-5-(2-methylpropanoyloxy)pent-2-en-3-yl]disulfanyl]pent-3-enyl] 2-methylpropanoate,CHEMBL2105813,NCGC00167456-01,Bisibuthiamine (JAN),Bisibuthiamine,bisibuthiamine,CS-7920

Market name: sulbutiamine

Estimated data

Solubilidad: -6.164 (log(S) in mol/L prediction using SolTranNet)

Addictivity Prediction: 34.8% (prediction based on www.mdpi.com)

Similitudes

The following is a set of comparisons to understand the properties of this compound. This is still higly experimental and is still under active development. Please refer to our series of blog posts to fully understand our approach and its limitations. This information is for informational purposes only and should not be construed as medical advice.